wound care - Nursing Case Study
Pathophysiology
• Primary mechanism: Inflammation - This initial response is crucial for wound healing, involving vasodilation and increased permeability to allow essential immune cells to reach the wound site, leading to redness and swelling.
• Secondary mechanism: Proliferation - Fibroblasts synthesize collagen and extracellular matrix, promoting new tissue formation and angiogenesis to re-establish blood supply. This phase is essential for wound closure and strength.
• Key complication: Infection - Disruption of normal healing can occur if pathogens invade, leading to prolonged inflammation and impaired tissue regeneration. Early detection and management are vital to prevent chronic wounds.
Patient Profile
Demographics:
52-year-old male, construction worker
History:
• Key past medical history: Type 2 diabetes, hypertension
• Current medications: Metformin, Lisinopril
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Worsening wound on left lower leg
• Key symptoms: Increased redness, swelling, and pain around the wound, slight fever, occasional chills
• Vital signs: Temperature 100.4°F, heart rate 92 bpm, blood pressure 138/88 mmHg, respiratory rate 20 breaths per minute
Section 1
During the initial assessment, the clinical team observed that the wound on the patient's left lower leg had expanded, displaying increased erythema and warmth extending beyond the original margins. Palpation of the area revealed tenderness and induration, suggesting possible cellulitis. The wound bed was covered in a yellowish exudate, indicative of possible infection, and there was a noticeable absence of healthy granulation tissue, signaling impaired healing. The patient's pain level was self-reported as 7 out of 10, and he expressed difficulty bearing weight on the affected leg due to discomfort.
Laboratory tests were ordered to further assess the situation. The complete blood count (CBC) showed leukocytosis with a white blood cell count of 14,000/mm³, with an elevated neutrophil count, suggesting an ongoing inflammatory response likely due to infection. Additionally, an elevated C-reactive protein (CRP) level of 25 mg/L further supported the presence of significant inflammation. Blood glucose levels were also checked, revealing poor glycemic control with a fasting blood sugar of 180 mg/dL, which could complicate wound healing and increase the risk of infection.
These findings prompted the healthcare team to initiate a more aggressive treatment plan to manage the infection and facilitate healing. Broad-spectrum antibiotics were prescribed, taking into account the patient's penicillin allergy, and adjustments were made to the patient's diabetic management to improve blood sugar control. The team also planned to perform a wound culture to identify the specific pathogen responsible for the infection, allowing for targeted antibiotic therapy. This comprehensive approach aimed to address the infection and support the body's natural healing processes, while continuous monitoring would be essential to evaluate the response to intervention and adjust the care plan as needed.
Section 2
After 48 hours of initiating the new treatment plan, the healthcare team conducted a follow-up assessment to evaluate the patient's response to interventions. The patient's vital signs remained stable, although he exhibited a low-grade fever with a temperature of 100.4°F, suggesting a persistent inflammatory process. Despite the introduction of broad-spectrum antibiotics, the erythema around the wound had not significantly reduced, and the area of induration seemed to have expanded slightly. The patient's pain persisted, still rated at 7 out of 10, indicating inadequate symptom relief and possibly ongoing infection or tissue inflammation.
New diagnostic results from the wound culture returned, identifying methicillin-resistant Staphylococcus aureus (MRSA) as the causative pathogen. This result necessitated a change in the antibiotic regimen to a more targeted approach, using vancomycin, given the organism's resistance profile. Concurrently, the patient's blood glucose levels showed some improvement with adjusted diabetic management, though fasting levels remained somewhat elevated at 160 mg/dL, requiring further optimization.
These findings prompted the clinical team to re-evaluate the patient's overall management plan. The presence of MRSA underscored the need for stringent infection control measures and reinforced the importance of enhancing glycemic control as a critical component of wound healing. The team decided to consult with an infectious disease specialist to ensure appropriate antibiotic dosing and to discuss potential adjunctive therapies, such as debridement or negative pressure wound therapy, to promote healing. This collaborative, multidisciplinary approach aimed to address both the immediate infection and the underlying factors impeding recovery, ensuring a comprehensive plan tailored to the patient's evolving needs.
Section 3
The team implemented the updated treatment plan, including vancomycin administration and stringent infection control measures. Within 24 hours, a noticeable change in the patient's wound was observed. The erythema began to recede slightly, and the margins of induration showed early signs of softening, suggesting a positive response to the targeted antibiotic therapy. However, the patient's pain level remained high, at 6 out of 10, indicating ongoing discomfort likely due to tissue inflammation and possibly neuropathic elements given his diabetic status. The infectious disease specialist recommended continuing vancomycin therapy, with plans to reassess serum trough levels to ensure therapeutic efficacy.
Despite initial improvements in wound appearance, the patient developed a new complication—an increase in bilateral lower extremity edema, raising concerns about potential fluid overload or venous insufficiency. The patient's weight had increased by 2 kg over the past 48 hours, and lung auscultation revealed faint crackles at the bases, though he remained hemodynamically stable with a blood pressure of 138/82 mmHg and heart rate of 88 beats per minute. The clinical team initiated diuretic therapy to manage potential fluid retention and planned for a cardiology consult to evaluate the possibility of underlying heart failure contributing to the edema.
These developments highlighted the need for careful monitoring of fluid status and cardiovascular function, as well as ongoing reassessment of the wound healing trajectory. The team emphasized the importance of maintaining glycemic control, as the patient's fasting blood glucose remained at 155 mg/dL, requiring further titration of insulin therapy. The integration of these various clinical elements underscored the complexity of managing a multifaceted case, with the goal of preventing further complications and achieving optimal healing outcomes.
Section 4
The clinical team continued to monitor the patient closely, prioritizing the management of his fluid status and evaluating the impact of the interventions. Within 48 hours of initiating diuretic therapy, the patient's bilateral lower extremity edema showed slight improvement, with a reduction in pitting edema from 3+ to 2+. However, the cardiology consult revealed that the patient had a reduced ejection fraction of 40%, suggesting the presence of systolic heart failure. This new finding necessitated adjustments in the patient's medication regimen to address both heart failure and fluid management effectively. The cardiologist recommended starting the patient on an ACE inhibitor to improve cardiac function and advised close monitoring of renal function and electrolytes.
In parallel, the wound care team observed that the wound continued to show signs of improvement, with further reduction in erythema and induration, and early granulation tissue formation was noted. Despite these positive changes, the patient's pain level persisted at 5 out of 10, indicating the need for a comprehensive pain management strategy. The team considered adding neuropathic pain agents, given the patient's diabetic history, to improve his comfort and enhance mobility, which is crucial for overall recovery.
These developments brought to light the interconnectedness of cardiovascular health, fluid balance, glycemic control, and wound healing in this patient. The interdisciplinary team remained vigilant, recognizing the potential for new complications and the importance of fine-tuning the treatment plan to address the evolving clinical picture. The focus was on achieving stable fluid balance, optimizing cardiac function, and ensuring adequate wound healing, all while keeping the patient's diabetes under control to facilitate better outcomes in the upcoming days.
Section 5
As the interdisciplinary team continued to manage the patient's complex clinical picture, a change in patient status emerged over the following days. The patient began to experience increased fatigue and a sensation of breathlessness, which raised concerns about the stability of his heart failure. On assessment, his vital signs revealed a blood pressure of 95/60 mmHg, heart rate of 110 bpm, and respiratory rate of 22 breaths per minute. Oxygen saturation had dropped to 90% on room air, necessitating supplemental oxygen via nasal cannula to maintain adequate oxygenation. Auscultation of the lungs indicated the presence of new bilateral crackles, suggesting pulmonary congestion.
Concurrently, routine laboratory tests revealed a slight increase in serum creatinine from 1.2 mg/dL to 1.6 mg/dL, indicative of potential renal impairment, possibly exacerbated by the introduction of the ACE inhibitor. Electrolyte levels showed a mild elevation in potassium at 5.5 mEq/L, raising the concern for hyperkalemia, a known side effect of ACE inhibitors. The team recognized the importance of balancing the benefits of improved cardiac function against the risk of renal complications and electrolyte imbalances.
In response to these developments, the clinical team adjusted the patient's diuretic dosage to address fluid overload while considering the impact on renal function. The cardiologist also evaluated the necessity of continuing the ACE inhibitor or modifying the treatment plan to prevent further renal compromise and electrolyte disturbances. The priority was to stabilize the patient's cardiovascular and renal status while closely monitoring his response to these interventions. This unfolding situation underscored the critical need for ongoing assessment and timely adjustments to the therapeutic regimen, emphasizing the interconnectedness of these systems and the importance of a coordinated, patient-centered approach to care.